ondansetron has been researched along with Eye Disorders in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cinar, E | 1 |
| Sanci, E | 1 |
| Utku, HS | 1 |
| Ozbek, AE | 1 |
| Bach-Styles, T | 1 |
| Martin-Sheridan, D | 1 |
| Hughes, C | 1 |
| Kaufman, S | 1 |
1 trial available for ondansetron and Eye Disorders
| Article | Year |
|---|---|
Comparison of ondansetron, metoclopramide, and placebo in the prevention of postoperative emesis in children undergoing ophthalmic surgery.
Topics: Adolescent; Antiemetics; Child; Child, Preschool; Eye Diseases; Humans; Infant; Metoclopramide; Onda | 1997 |
1 other study available for ondansetron and Eye Disorders
| Article | Year |
|---|---|
Ondansetron-induced oculogyric crisis in a pediatric patient: case report.
Topics: Antiemetics; Child; Eye Diseases; Humans; Ondansetron; Vomiting | 2023 |